{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:43Z","timestamp":1791583183729,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jaci.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T07:11:03Z","timestamp":1525331463000},"page":"1543-1551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":216,"title":["Endotype-driven care pathways in patients with chronic rhinosinusitis"],"prefix":"10.1016","volume":"141","author":[{"given":"Claus","family":"Bachert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bousquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2018.03.004_bib1","first-page":"1","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.jaci.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2014an underestimated disease. A\u00a0GA2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaci.2011.08.004","article-title":"Chronic rhinosinusitis: epidemiology and medical management","volume":"128","author":"Hamilos","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2018.03.004_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/all.12983","article-title":"Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre","volume":"72","author":"van der Veen","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/all.13162","article-title":"ARIA and EPOS working groups. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis\u2014A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement","volume":"72","author":"Hellings","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00183169","article-title":"Functional endoscopic sinus surgery. Concept, indications and results of the Messerklinger technique","volume":"247","author":"Stammberger","year":"1990","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaci.2018.03.004_bib9","first-page":"73","article-title":"Indications, technique and results of\u00a0endonasal endoscopic ethmoidectomy","volume":"47","author":"Hosemann","year":"1993","journal-title":"Acta Otorhinolaryngol Belg"},{"issue":"suppl\u00a022","key":"10.1016\/j.jaci.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1399-3038.2012.01318.x","article-title":"Chronic rhinosinusitis: from one disease to different phenotypes","volume":"23","author":"Bachert","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaip.2016.05.004","article-title":"Phenotypes and emerging endotypes of chronic rhinosinusitis","volume":"4","author":"Bachert","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"suppl","key":"10.1016\/j.jaci.2018.03.004_bib14","first-page":"S1","article-title":"Clinical practice guideline (update): adult sinusitis","volume":"152","author":"Rosenfeld","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2018.03.004_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE-antibodies to staphylococcal enterotoxins in nasal polyps is associated with co-morbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2500\/ajra.2014.28.4033","article-title":"Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps","volume":"28","author":"Van Zele","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jaci.2017.07.031","article-title":"Serum periostin, IgE and SE-IgE can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps","volume":"140","author":"Jonstam","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0194599817737967","article-title":"Periostin as a biomarker for nasal polyps in chronic rhinosinusitis","volume":"158","author":"Maxfield","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2018.03.004_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/lio2.32","article-title":"A review of classification schemes for chronic rhinosinusitis with nasal polyposis endotypes","volume":"1","author":"Dennis","year":"2016","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.jaci.2018.03.004_bib20","doi-asserted-by":"crossref","first-page":"e0136068","DOI":"10.1371\/journal.pone.0136068","article-title":"Association of mucosal organisms with patterns of inflammation in chronic rhinosinusitis","volume":"10","author":"Chalermwatanachai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2018.03.004_bib21","article-title":"Impact of allergy on phenotypic and endotypic profiles of nasal polyposis","author":"Mortuaire","year":"2017","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.jaci.2018.03.004_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2500\/ajra.2017.31.4405","article-title":"Peripheral blood T-helper cells and eosinophil populations in patients with atopic and nonatopic chronic rhinosinusitis","volume":"31","author":"Huang","year":"2017","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaci.2017.08.039","article-title":"Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis","volume":"141","author":"Steelant","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4168\/aair.2015.7.4.367","article-title":"TMEM16A-mediated mucin secretion in IL-13-induced nasal epithelial cells from Chronic rhinosinusitis patients","volume":"7","author":"Zhang","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2018.03.004_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1398-9995.2010.02498.x","article-title":"Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis","volume":"66","author":"Krysko","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201701-0120OC","article-title":"Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma","volume":"196","author":"Esquivel","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2018.03.004_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/all.12054","article-title":"Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps","volume":"68","author":"Gevaert","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaci.2016.11.015","article-title":"Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis","volume":"140","author":"Van Roey","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib31","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jaci.2017.01.019","article-title":"Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in severe airway inflammation","volume":"139","author":"Gevaert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.201207-1292OC","article-title":"Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression","volume":"187","author":"Takabayashi","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2018.03.004_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jprot.2017.01.008","article-title":"Characterization of human and Staphylococcus aureus proteins in respiratory mucosa by in\u00a0vivo- and immunoproteomics","volume":"155","author":"Schmidt","year":"2017","journal-title":"J Proteomics"},{"key":"10.1016\/j.jaci.2018.03.004_bib34","article-title":"Staphylococcus aureus controls interleukin-5 release in upper airway inflammation possibly via secreted proteins","author":"Bachert","year":"2017","journal-title":"J Proteomics"},{"key":"10.1016\/j.jaci.2018.03.004_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaci.2016.03.045","article-title":"Spls: Staphylococcus serine protease-like proteins are pacemakers of allergic airway reactions","volume":"139","author":"Stentzel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2017.05.004","article-title":"The IL-33\/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D","volume":"141","author":"Teufelberger","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib37","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jaci.2017.10.006","article-title":"Chronic rhinosinusitis: endotypes, biomarkers, and treatment response","volume":"140","author":"Gurrola","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaci.2018.03.004_bib39","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of T-helper cytokine-profiles in chronic rhinosinusitis: a multicenter study in Europe, Asia and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib40","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jaci.2017.09.009","article-title":"Chronic rhinosinusitis in Asia: current perspectives","volume":"140","author":"Zhang","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib41","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jaci.2012.01.079","article-title":"Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy","volume":"129","author":"Wen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.jaci.2018.03.004_bib42","first-page":"CD002997","article-title":"Macrolides for chronic asthma","author":"Kew","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2018.03.004_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jaip.2015.12.008","article-title":"Are antibiotics useful for chronic rhinosinusitis?","volume":"4","author":"Bachert","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.03.004_bib44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/all.12451","article-title":"Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459","volume":"69","author":"Pettipher","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00005537-200405000-00004","article-title":"Recurrence rates after endoscopic sinus surgery for massive sinus polyposis","volume":"114","author":"Wynn","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2018.03.004_bib46","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/alr.21739","article-title":"Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis","volume":"6","author":"Morrissey","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2018.03.004_bib47","first-page":"131","article-title":"Comparison of radical (nasalisation) and functional ethmoidectomy in patients with severe sinonasal polyposis. A\u00a0retrospective study","volume":"127","author":"Jankowski","year":"2006","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"key":"10.1016\/j.jaci.2018.03.004_bib48","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/lary.20653","article-title":"Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis","volume":"119","author":"Hopkins","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2018.03.004_bib49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/0194599814565606","article-title":"Early versus delayed endoscopic sinus surgery in patients with chronic rhinosinusitis: impact on health care utilization","volume":"152","author":"Benninger","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2018.03.004_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4193\/Rhino14.077","article-title":"Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Retrospective analysis using the UK clinical practice research data","volume":"53","author":"Hopkins","year":"2015","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2018.03.004_bib51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jaip.2017.04.038","article-title":"Biologic therapy and novel molecular targets of severe asthma","volume":"5","author":"Pepper","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2018.03.004_bib52","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: a randomised trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaci.2012.07.027","article-title":"Novel targeted therapies for eosinophilic disorders","volume":"130","author":"Wechsler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and non-allergic patients with nasal polyposis and co-morbid asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2018.03.004_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4193\/Rhin16.314","article-title":"The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps","volume":"55","author":"De Schryver","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2018.03.004_bib57","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2018.03.004_bib58","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1164\/rccm.201606-1145LE","article-title":"Omalizumab is associated with reduced acute severity of rhinovirus-triggered asthma exacerbation","volume":"194","author":"Kantor","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2018.03.004_bib59","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations","volume":"136","author":"Teach","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib60","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","article-title":"Oral steroids and doxycycline in nasal polyps: two different approaches to treat nasal polyps","volume":"125","author":"Van Zele","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2018.03.004_bib61","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1445-5994.2011.02481.x","article-title":"Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids","volume":"41","author":"Domingo","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaci.2018.03.004_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01782-2017","article-title":"Care pathways for the selection of a biologic in severe asthma","volume":"50","author":"Bousquet","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2018.03.004_bib63","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.rmed.2007.01.011","article-title":"Predicting and evaluating response to omalizumab in patients with severe allergic asthma","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2018.03.004_bib64","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1183\/09031936.00014614","article-title":"Integrated care pathways for airway diseases (AIRWAYS-ICPs)","volume":"44","author":"Bousquet","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2018.03.004_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13601-016-0137-4","article-title":"ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle","volume":"6","author":"Bousquet","year":"2016","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2018.03.004_bib66","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4193\/Rhin17.221","article-title":"Rhinology Future Debates, an EUFOREA Report","volume":"55","author":"Fokkens","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2018.03.004_bib67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MCP.0000000000000231","article-title":"Role of T2 inflammation biomarkers in severe asthma","volume":"22","author":"Parulekar","year":"2016","journal-title":"Curr Opin Pulm Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918304500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918304500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:08:43Z","timestamp":1758791323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918304500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0091674918304500"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733181300.793553600","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endotype-driven care pathways in patients with chronic rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}